YATHARTH HOSPITAL share price has zoomed 6% and is presently trading at Rs 618.0.
Meanwhile, the BSE HEALTHCARE index is at 43,128.2 (up 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 3.8%) and LAURUS LABS (up 2.2%).
MAX HEALTHCARE INSTITUTE (down 2.3%) and GLAND PHARMA (down 2.0%) are among the top losers today.
Over the last one year, YATHARTH HOSPITAL has moved up from Rs 366.4 to Rs 618.0, registering a gain of Rs 251.6 (up 68.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,128.2, registering a gain of 56.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 219.1%), SUVEN PHARMACEUTICALS (up 128.4%) and Glenmark Pharma (up 126.1%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 80,324.5 (up 0.1%).
The top gainers among the BSE Sensex today are Bajaj Finance (up 5.5%) and Tech Mahindra (up 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,532.7 (up 0.3%). Bajaj Finance and Bajaj Auto are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,324.5, registering a gain of 15,752.7 points (up 24.4%).
YATHARTH HOSPITAL net profit grew 59.6% YoY to Rs 304 million for the quarter ended June 2024, compared to a profit of Rs 190 million a year ago. Net sales rose 37.1% to Rs 2,118 million during the period as against Rs 1,545 million in April-June 2023.
For the year ended March 2024, YATHARTH HOSPITAL reported 74.1% increase in net profit to Rs 1,145 million compared to net profit of Rs 658 million during FY23. Revenue of the company grew 28.9% to Rs 6,705 million during FY24.
The current Price to earnings ratio of YATHARTH HOSPITAL, based on rolling 12 month earnings, stands at 42.2.
Equitymaster requests your view! Post a comment on "YATHARTH HOSPITAL Gains 6%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!